Document:

Description of Share Redemption Program

 Exhibit 4.4 
 Description of Share Redemption Program 
 As used herein, the terms “we,”
“our” and “us” refer to Wells Real Estate Investment Trust II, Inc. 
 Our board of directors has further amended our
share redemption program, which enables stockholders to sell their shares to us, subject to the limitations described below. The amendment, which will go into effect September 9, 2006 grants us discretion to redeem all shares submitted for
redemption upon the death of stockholders. Set forth below is a full description of our amended share redemption program. 
 For Ordinary
Redemptions (those that do not occur within two years of death or “qualifying disability”, as defined below), the initial price at which we will repurchase a share under the share redemption program is 91% of the price at which we sold the
share. We will pay $9.10 to redeem a share issued at $10.00. This initial redemption price will remain fixed until three years after we complete our offering stage. We define the completion of our offering stage to be upon the termination of our
first public equity offering that is followed by a one-year period in which we do not engage in another public equity offering. (For purposes of this definition, we do not consider a “public equity offering” to include offerings on behalf
of selling stockholders or offerings related to a dividend reinvestment plan, employee benefit plan or the redemption of interests in our operating partnership). 
 Three years after we complete our offering stage, the redemption price for Ordinary Redemptions will equal 95% of the estimated per share value of our shares, as estimated by our advisor or another firm chosen for
that purpose. We will report this redemption price in the annual report and the three quarterly reports that we publicly file with the SEC. 
 There are several limitations on our ability to redeem shares: 
  

	 	•	 	We will not make an Ordinary Redemption until one year after the issuance of the share to be redeemed. 

  

	 	•	 	We will not redeem shares on any redemption date to the extent that such redemptions would cause the amount paid for Ordinary Redemptions since the beginning of the then-current
calendar year to exceed 50% of the net proceeds from the sale of shares under our dividend reinvestment plan during such period. 

  

	 	•	 	We will limit Ordinary Redemptions and those upon the “qualifying disability” of a stockholder so that the aggregate of such redemptions during any calendar year do not
exceed: 

  

	 	•	 	100% of the net proceeds from our dividend reinvestment plan during the calendar year or 

  

	 	•	 	5% of the weighted-average number of shares outstanding in the prior calendar year. 

 Although there is no limit on the number of shares we may redeem upon the death of stockholders, we are under no
obligation to redeem such shares to the extent such redemptions would cause total redemptions to exceed the two limits set forth immediately above. 
 Subject to the limitations described above, we will redeem shares on the last business day of each month. Requests for redemption must be received at least five business days before a month-end redemption date in order for us to repurchase
the shares that month. If we cannot purchase all shares presented for redemption, we will honor redemption requests at the applicable month-end on a pro rata basis. We will deviate from pro rata purchases in two minor ways: (i) if a pro rata
redemption would result in you owning less than half of the minimum amount required by applicable state law, then we would redeem all of your shares; and (ii) if a pro rata redemption would result in you owning more than half but less than all
of the amount required by applicable state law, then we would not redeem any shares that would reduce your holdings below the minimum amount. In the event that you seek the redemption of all of your shares, there is no holding-period requirement for
shares purchased pursuant to our dividend reinvestment plan. 
 If we do not completely satisfy your redemption request at month-end because
the request was not received in time or because of the restrictions on the number of shares we can redeem under the program, we will treat the unsatisfied portion of the redemption request as a request for redemption in the following month unless
you withdraw the request before the next date for redemptions. You may withdraw a redemption request upon written notice to us at the address below before the date for redemption. 
 In several respects we treat redemptions sought within two years of a stockholder’s death or “qualifying disability” differently from
Ordinary Redemptions. First, there is no requirement that the shares be outstanding for at least a year before being redeemed. Second, the redemption price equals 100% of the price at which we sold the share until three years after we complete our
offering stage. At that time, the redemption price will be 100% of the price at which we sold the share or 100% of the estimate of our per share value, whichever is greater. Finally, as explained above, there is no limit on the number of shares we
may redeem upon the death of stockholders. 
 In order for a disability to entitle a stockholder to the special redemption terms described
above (a “qualifying disability”), (1) the stockholder must receive a determination of disability based upon a physical or mental condition or impairment arising after the date the stockholder acquired the shares to be redeemed, and
(2) such determination of disability must be made by the governmental agency responsible for reviewing the disability retirement benefits that the stockholder could be eligible to receive (the “applicable governmental agency”). The
“applicable governmental agencies” are limited to the following: (i) if the stockholder paid Social Security taxes and therefore could be eligible to receive Social Security disability benefits, then the applicable governmental agency
is the Social Security Administration or the agency charged with responsibility for administering Social Security disability benefits at that time if other than the Social Security Administration; (ii) if the stockholder did not pay Social
Security benefits and therefore could not be eligible to receive Social Security disability benefits, but the stockholder could be eligible to receive disability benefits under the Civil Service Retirement 

 
System (“CSRS”), then the applicable governmental agency is the U.S. Office of Personnel Management or the agency charged with responsibility for
administering CSRS benefits at that time if other than the Office of Personnel Management; or (iii) if the stockholder did not pay Social Security taxes and therefore could not be eligible to receive Social Security benefits but suffered a
disability that resulted in the stockholder’s discharge from military service under conditions that were other than dishonorable and therefore could be eligible to receive military disability benefits, then the applicable governmental agency is
the Veteran’s Administration or the agency charged with responsibility for administering military death benefits at that time if other than the Veteran’s Administration. 
 Disability determinations by governmental agencies for purposes other than those listed above, including but not limited to worker’s compensation
insurance, administration or enforcement of the Rehabilitation Act or Americans with Disabilities Act or waiver of insurance premiums, will not entitle a stockholder to the special redemption terms described above. Redemption requests following an
award by the applicable governmental agency of disability benefits must be accompanied by: (1) the investor’s initial application for disability benefits and (2) a Social Security Administration Notice of Award, a U.S. Office of
Personnel Management determination of disability under CSRS, a Veteran’s Administration record of disability-related discharge or such other documentation issued by the applicable governmental agency that we deem acceptable and demonstrates an
award of the disability benefits. 
 We understand that the following disabilities do not entitle a worker to Social Security disability
benefits: 
  

	 	•	 	disabilities occurring after the legal retirement age, 

  

	 	•	 	temporary disabilities and 

  

	 	•	 	disabilities that do not render a worker incapable of performing substantial gainful activity. 

 Therefore, such disabilities will not qualify for the special redemption terms except in the limited circumstances when the investor is awarded
disability benefits by the other “applicable governmental agencies” described above. 
 A stockholder that is a trust may only
redeem on the terms available in connection with the death or disability of a stockholder if the deceased or disabled was the sole beneficiary of the trust or if the only other beneficiary of the trust was the spouse of the deceased or disabled.

 Qualifying stockholders who desire to redeem their shares must give written notice to Wells Investment Securities, our dealer manager for
our ongoing public offering, at 6200 The Corners Parkway, Suite 250, Norcross, Georgia 30092, ATTN: Investor Services. Wells Investment Securities is responsible for all services to be performed in connection with the share redemption program,
although it has outsourced clerical duties to our advisor. 

 Our board of directors may amend, suspend or terminate the share redemption program upon 30 days’
notice. However, under the terms of our recently amended Corporate Governance Guidelines, until a secondary market develops for shares of our common stock or our board’s decision to commence a liquidation of the company, we may not amend the
share redemption program in a way that materially adversely affects the rights of redeeming heirs without the approval of our stockholders. We will notify you of any amendment, suspension or termination of the share redemption program (i) in
the annual or quarterly reports mentioned above or (ii) by means of a separate mailing, accompanied by disclosure in a current or periodic report under the Securities Exchange Act of 1934. During a public offering, we will also include this
information in a prospectus supplement or post-effective amendment to the registration statement, as then required under federal securities laws. 
 Our share redemption program only provides stockholders a limited ability to redeem shares for cash until a secondary market develops for the shares, at which time the program will terminate. No such market presently exists, and we cannot
assure you that any market for your shares will ever develop. 
 On June 16, 2006, in connection with this amendment to our share
redemption program, we entered into an insurance agreement with an affiliate of London Life and Casualty Reinsurance Corporation, to provide us with an insurance-backed funding source for the redemption of the shares under our share redemption
program in the event we receive an unusually large number of redemption requests due to the death of investors. The funding for redemptions under the share redemption program was previously funded solely from funds received from our dividend
reinvestment plan. After the deductible has been met under this insurance agreement, funds will be disbursed to us, upon receipt of a share re-registration or redemption request due to the death of a stockholder. 
 In accordance with this insurance agreement, the share redemption program insurance proceeds will be paid to us after a quarterly adjusted deductible,
currently $1.8 million for the quarter ending September 30, 2006, is met. The deductible adjusts with additional investment proceeds raised and with the changing demographics of our stockholder base (age, gender, etc.). The maximum dollar value
of proceeds that we can collect under the insurance agreement is $6.0 billion in aggregate or $5.0 million for any individual redemption request. The insurance agreement has a 10-year term unless it expires earlier upon the occurrence of one of the
following liquidity events: (i) the listing of our shares on a national exchange, (ii) our liquidation, or (iii) the acquisition of a majority of our shares by an unaffiliated entity or a merger in which we are not the surviving
entity. We may elect to terminate the insurance agreement at any time with 30 days’ written notice, subject to a $0.1 million termination fee and possible penalty. The board has agreed to seek the approval of our stockholders prior to
terminating this insurance program.Amendment to Employment Agreement

 EXHIBIT 10.1 
 FIRST AMENDMENT TO EMPLOYMENT AGREEMENT 
 BETWEEN DR. YAWEN L. CHIANG AND CORAUTUS GENETICS, INC.

 This FIRST AMENDMENT to that certain EMPLOYMENT AGREEMENT between Corautus Genetics, Inc. (the “Company”) and Dr. Yawen L.
Chiang (the “Executive”) dated October 1, 2005 (the “Agreement”) is hereby entered into by and between the Company and the Executive effective as of the 15th day of May, 2006. 
 W I T N E S S E T H: 
 WHEREAS,
the Company and the Executive are parties to the Agreement; and 
 WHEREAS, due to the precipitous drop in the value of the stock
of the Company following the termination of the enrollment of patients in the GENASIS Phase IIb Clinical Trial in April 2006, the Company has deemed it necessary to provide the Executive with incentives to continue in the employ of the Company; and

 WHEREAS, the Board of Directors of the Company approved this amendment to the Agreement to include certain retention incentives to
encourage the Executive to continue her employment with the Company, to increase the likelihood of retaining the Executive and to create stability within the Company; 
 NOW, THEREFORE, effective as of May 15, 2006, the parties hereby amend the Agreement as follows: 
 1. A new
Article 7 shall be added to the Agreement to read as follows: 
 “ARTICLE 7 
 RETENTION INCENTIVES 
 7.1 Cash
Retention Payment. The Executive shall be entitled to receive a lump sum cash payment of $55,000 if she is employed by the Company on September 30, 2006. The Executive shall be entitled to receive an additional lump sum cash payment of
$55,000 if she is employed by the Company on March 31, 2007. If the Executive is employed on the date(s) provided herein, the cash payment(s) shall be paid to the Executive no later than the next regularly scheduled payroll date following the
date the Executive becomes entitled to such payment. 
 7.2 Nonqualified Stock Option Award. In accordance with and subject to
the terms of the Corautus Genetics Inc. 2002 Stock Plan (the “Plan”), the Company agrees to grant to the Executive nonqualified stock options to purchase 100,000 shares of the Company’s common stock according to the following terms
and conditions (any additional terms and conditions of such option grant to be as specified in the option agreement): 
 (a) The date of grant
shall be the effective date of this First Amendment to the Agreement; 

 (b) The per share option exercise price shall be the fair market value per share (as defined in the Plan)
on the date of grant; 
 (c) The options shall become exercisable as follows: 
 (i) 50,000 of the option shares shall become exercisable on March 31, 2007 if the Executive is employed by the Company on that date; and 

(ii) The remaining 50,000 option shares shall become exercisable on March 31, 2008 if the Executive is employed by the Company on that date.

 (d) The options shall have a 10-year term and, except as specified herein, shall be subject to the terms and provisions of the Plan; and

 (e) Once exercisable, the options shall remain exercisable following termination of employment only as provided under the terms of the
Plan.” 
 2. Except as specifically provided above, the terms of the Agreement shall remain in full force and effect as prior to this First Amendment.

 IN WITNESS WHEREOF, the Executive and the Company have executed and delivered this First Amendment to the Agreement as of the date
set forth above, but actually on the date set forth below. 
  

			
	CORAUTUS GENETICS, INC.
		
	By:	 	 /s/ Richard E. Otto

		 	Richard E. Otto
		 	President and CEO
		
	Date:	 	May 15, 2006
	
	YAWEN L. CHIANG
	
	 /s/ Yawen L. Chiang

		
	Date:	 	May 15, 2006

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00108-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00108-of-00352.parquet"}]]